No detectable vaginal antibiotic activity in nearly a third of BV episodes

An observational study measured vaginal antibiotic activity (VAA) after metronidazole prescription for bacterial vaginosis and its relationship to clinical and microbiological outcomes. The study reported no detectable VAA in 31% of episodes within 10 days post-diagnosis, and VAA present for the majority of prescribed days was associated with reduced early recurrence (days 6-35) only when condomless sex was not reported; no association with VAA was found for recurrence at days 36-100. The authors concluded that the combination of metronidazole detection on most prescribed days and condom use was associated with reduced risk of BV recurrence.

Most relevant for: Women being treated with metronidazole for bacterial vaginosis, particularly those with a history of recurrence.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.